Preview

Strategic Analysis of the Pharmaceutical Industry

Powerful Essays
Open Document
Open Document
1913 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Strategic Analysis of the Pharmaceutical Industry
STRATEGIC ANALYSIS OF THE WORLD PHARMACEUTICAL INDUSTRY
Dragan Kesič∗
Received: 28. 2. 2007 Case study
Accepted: 9. 7. 2008 UDC 65.01:615
The world pharmaceutical industry has been changing profoundly in the last decade. Intensive globalization, increased competitiveness and the fight for global market shares create new challenges for pharmaceutical companies. Fast globalization definitively reinforces the consolidation of the world pharmaceutical industry. Alliancing in forms of mergers and acquisitions prevail more and more as a strategic orientation for the world pharmaceutical companies. By alliancing, they tend to create strategic synergies in an endeavour to be successful, competitive and capable to continue with further development circles. The pharmaceutical industry in Eastern Europe has been, to a great majority, taken-over by their multi-national peer companies, thus creating completely new managerial challenges. One may forecast that intensive alliancing processes in the world pharmaceutical industry are to continue to form even bigger pharmaceutical concerns and speed up the oligopolization of the global pharmaceutical industry. It can be concluded that strategic management with a dedicated market focus is to play an even more important and especially the highest top priority function in future globalization and consolidation processes of the world pharmaceutical industry.
1. CHARACTERISTICS OF THE WORLD PHARMACEUTICAL INDUSTRY
One may define the main characteristics of the world pharmaceutical industry as follows:

increased globalization,
∗ Dr. Dragan Kesič, Assistant Professor, University of Primorska, Faculty of Management Koper, Slovenia, Department of Marketing and International Business, Phone: +386 5 610 20 44, Fax: +386 5 610 20 15, E-mail: dragan.kesic@fm-kp.si 59
Management, Vol. 14, 2009, 1, pp. 59-76
D. Kesič: Strategic analysis of the world pharmaceutical industry

changing structure of competition and increased

You May Also Find These Documents Helpful

  • Powerful Essays

    Vw Marketing

    • 15650 Words
    • 63 Pages

    AP Degree in Marketing Management Author: Patryk Borkowski 144008 Assignment: Final Project Supervisor: Erik Løvgren Brejner Characters: 94 568Submitted: 30th of May 2012…

    • 15650 Words
    • 63 Pages
    Powerful Essays
  • Powerful Essays

    Chinese Negotiation Style

    • 11432 Words
    • 46 Pages

    Citations: Journal of Business & Industrial Marketing 21/1 (2006) 50– 60 q Emerald Group Publishing Limited [ISSN 0885-8624] [DOI 10.1108/08858620610643175]…

    • 11432 Words
    • 46 Pages
    Powerful Essays
  • Powerful Essays

    Allstar Brands' over-the-counter cold and allergy remedy Allround will continue to be the market leader among OTC cold medicines and continue to increase its stock price over the next decade in order to remain not only competitive, but the premier stock choice among competitors in the OTC cold and allergy remedy market. To further grow the Allround product it is essential to build upon the current strengths of the brand, but also seek additional areas for opportunity and growth. These goals will be accomplished by evaluating competitors entering the OTC cold and allergy remedy market and through careful planning and execution to enhance our current product to meet the desires and needs of consumers.…

    • 1765 Words
    • 8 Pages
    Powerful Essays
  • Good Essays

    JCPenney's repositioning

    • 704 Words
    • 3 Pages

    This article is by Alexander Chernev, associate professor of marketing at the Kellogg School of Management, Northwestern University.…

    • 704 Words
    • 3 Pages
    Good Essays
  • Best Essays

    Pfizer Industry Review

    • 4325 Words
    • 18 Pages

    Since the 1950s, the global pharmaceutical industry has evolved from “…a collection of several hundred, small, barely profitable firms to as small group of large, highly profitable firms” (Younkin, 2008, para. 1). This evolution has resulted in an oligopoly market structure with a few large firms, and significant barriers to market entry. In the last 20 years, pharmaceutical consolidation has continued with both vertical and horizontal mergers that have further shrunk the market. Since 1995, Pfizer has merged with five pharmaceutical firms (Industry Brief, 2003) in an attempt to increase its research and development divisions and to offset declines in new product development; increases in generic competition; and the emergence of bio-pharmaceutical firms (BCC Research, 2004). Although pharmaceutical firms no longer view mega mergers as “…a cure-all for [their] innovation drought” (Simons, 2007, para. 1), this trend towards consolidation is expected to continue, with firms focusing “…on targeted acquisitions and alliances with smaller…more innovative drug makers and biotechs” (Simons, 2007, para. 10).…

    • 4325 Words
    • 18 Pages
    Best Essays
  • Powerful Essays

    Analysis of the Medicines Company case revealed several critical aspects that need to be addressed. The pharmaceutical industry can be very profitable, but is also very risky. As described in the case, bringing a new drug to market is a costly and lengthy process requiring an average of 10 years. Big Pharmaceutical companies struggle to keep upcoming drugs in their pipeline to provide revenue when existing drugs come off patent and are replaced by generic compounds. With 1 in 4000 compounds making it to market, there is significant risk of failure that can be reduced by having many compounds in development. Additionally, a drug company's reputation can easily be tarnished by safety issues with a compound, dramatically affecting their sales.…

    • 2114 Words
    • 7 Pages
    Powerful Essays
  • Satisfactory Essays

    Generic brands have been profitable and cost efficient for buyers. This simply means that suppliers don’t need to offer a particular name brand; all they need have is the active ingredients that brand name suppliers that have the same function as name brand medications.…

    • 512 Words
    • 3 Pages
    Satisfactory Essays
  • Best Essays

    For the purposes of this report, we will perform a detailed overview of the pharmaceutical industry, including defining the industry and its strategic forces, an environmental analysis, the forces of competition within the industry and value chain analysis as well the role of IS/IT in the industry. Four companies will be individually researched within that industry and this individual analysis will include financial information as well as industry market sources. A clear plan will also be outlined for further analysis on these companies.…

    • 3312 Words
    • 14 Pages
    Best Essays
  • Best Essays

    References: AstraZeneca’s main six therapy areas represent a significant proportion of the worldwide burden of disease as projections indicate the burden of disease (chronic disease) will continue to increase next 20 years.…

    • 3585 Words
    • 15 Pages
    Best Essays
  • Powerful Essays

    Threat of new entrants is relatively high. Companies forming alliances are potential rivals. Even if earlier such company was not considered to be a threat, after merging with some research and development company or forming alliance with another pharmaceutical company it would become a rival to Eli Lilly. The threat is however weakened by significant research and development costs necessary to successfully enter the business. Eli Lilly’s focus on a relatively narrow market of sedatives and antidepressants weakens the threat of new entrants, but other products that form lesser part of company’s sales such as insulin and others are exposed to high threat of new entrants. The need of obtaining certificates and licenses also weakens the threat of new entrants. Discussed above leads to the conclusion that threat of new entrants is medium.…

    • 1398 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    Sales in 2008 totalled $31.6 billion. R&D investment totalled over $5 billion. It has around 12,000 people in our R&D organisation and 17…

    • 2438 Words
    • 10 Pages
    Powerful Essays
  • Powerful Essays

    The main key issues of this case are as follow. The pharmaceutical industry had come about through both forward integration from the manufacture of organic chemicals and a backward integration from druggist-supply houses. The industry’s rapid growth was aided by increasing worldwide incomes and a universal demand for better health care; however, most of the world markets for pharmaceuticals were concentrated in North America, Europe and Japan. Drug discovery was an expensive process, with leading firms spending more than 20 per cent of their sales on research and development (R&D). Developing a drug, from discovery to launch in a major market, took 10 to 12 years and typically cost US$500 million to US$800 million (in 1992). Bulk production of active…

    • 3230 Words
    • 13 Pages
    Powerful Essays
  • Better Essays

    All pharmaceutical companies have been built up their strategies to get the competitive advantage to take over their competitor. For the following sections, it will use PESTEL and Porter’s Five Forces to review the pharmaceutical industry.…

    • 964 Words
    • 4 Pages
    Better Essays
  • Satisfactory Essays

    • Increasing standards and requirements for environmental protection are becoming more stringent because of industry operations.…

    • 555 Words
    • 3 Pages
    Satisfactory Essays
  • Powerful Essays

    Since 2000 the Stock market valuation of the ‘Big Pharma’ companies has dropped sharply. Discuss the causes of the pharmaceutical industry’s current problems and steps that companies are taking to tackle them.…

    • 2528 Words
    • 11 Pages
    Powerful Essays